EE05308B1 - Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod - Google Patents

Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod

Info

Publication number
EE05308B1
EE05308B1 EEP200300294A EEP200300294A EE05308B1 EE 05308 B1 EE05308 B1 EE 05308B1 EE P200300294 A EEP200300294 A EE P200300294A EE P200300294 A EEP200300294 A EE P200300294A EE 05308 B1 EE05308 B1 EE 05308B1
Authority
EE
Estonia
Prior art keywords
sulfonamide
preparation
substituted imidazotriazinones
imidazotriazinones
substituted
Prior art date
Application number
EEP200300294A
Other languages
English (en)
Estonian (et)
Inventor
Nowakowski Marc
Gehring Reinhold
Heilmann Werner
Wahl Karl-Heinz
Original Assignee
Bayer Aktiengeshellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengeshellschaft filed Critical Bayer Aktiengeshellschaft
Publication of EE200300294A publication Critical patent/EE200300294A/xx
Publication of EE05308B1 publication Critical patent/EE05308B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
EEP200300294A 2000-12-18 2001-12-05 Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod EE05308B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10063108A DE10063108A1 (de) 2000-12-18 2000-12-18 Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
PCT/EP2001/014239 WO2002050076A2 (de) 2000-12-18 2001-12-05 Verfahren zur herstellung von sulfonamid-substituierten imidazotriazinonen

Publications (2)

Publication Number Publication Date
EE200300294A EE200300294A (et) 2003-10-15
EE05308B1 true EE05308B1 (et) 2010-06-15

Family

ID=7667666

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300294A EE05308B1 (et) 2000-12-18 2001-12-05 Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod

Country Status (43)

Country Link
US (3) US6777551B2 (pt)
EP (1) EP1345939B1 (pt)
JP (1) JP4441175B2 (pt)
KR (1) KR100787288B1 (pt)
CN (1) CN1227253C (pt)
AR (1) AR032775A1 (pt)
AT (1) ATE328885T1 (pt)
AU (2) AU1708902A (pt)
BG (1) BG66142B1 (pt)
BR (1) BRPI0116227B8 (pt)
CA (1) CA2431933C (pt)
CU (2) CU23341B7 (pt)
CY (1) CY1105197T1 (pt)
CZ (1) CZ297005B6 (pt)
DE (2) DE10063108A1 (pt)
DK (1) DK1345939T3 (pt)
DO (1) DOP2001000295A (pt)
EC (1) ECSP034657A (pt)
EE (1) EE05308B1 (pt)
ES (1) ES2266098T3 (pt)
GT (1) GT200100251A (pt)
HK (1) HK1063799A1 (pt)
HN (1) HN2001000278A (pt)
HR (1) HRP20030583B1 (pt)
HU (1) HU229296B1 (pt)
IL (2) IL156278A0 (pt)
MA (1) MA25927A1 (pt)
MX (1) MXPA03005429A (pt)
MY (1) MY126689A (pt)
NO (1) NO325398B1 (pt)
NZ (1) NZ526477A (pt)
PE (1) PE20020590A1 (pt)
PL (1) PL207294B1 (pt)
PT (1) PT1345939E (pt)
RU (1) RU2299211C2 (pt)
SI (1) SI1345939T1 (pt)
SK (1) SK286894B6 (pt)
SV (1) SV2003000766A (pt)
TW (1) TWI289562B (pt)
UA (1) UA75109C2 (pt)
UY (2) UY27070A1 (pt)
WO (1) WO2002050076A2 (pt)
ZA (1) ZA200304705B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE202004006552U1 (de) * 2004-04-26 2004-07-08 Knürr AG Kühlungssystem für Geräte- und Netzwerkschränke
DE102004023069A1 (de) 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US7977478B2 (en) * 2006-03-13 2011-07-12 Dr. Reddy's Laboratories Limited Polymorphic forms of vardenafil
WO2009030095A1 (en) * 2007-09-06 2009-03-12 Topharman Shanghai Co., Ltd. Process for preparing vardenafil and its intermediates
WO2009082845A1 (en) 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd. N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
WO2011016016A1 (en) 2009-08-07 2011-02-10 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
PL390079A1 (pl) * 2009-12-30 2011-07-04 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób otrzymywania wardenafilu i jego izolacji jako soli z kwasem cytrynowym oraz krystaliczna postać tej soli
CN102134242B (zh) 2011-01-21 2013-08-28 浙江大德药业集团有限公司 一种用于治疗阳痿的快速长效的化合物
CZ303877B6 (cs) * 2011-11-24 2013-06-05 Zentiva, K.S. Zpusob prípravy a izolace solí vardenafilu s kyselinami
WO2015089105A1 (en) 2013-12-09 2015-06-18 Respira Therapeutics, Inc. Pde5 inhibitor powder formulations and methods relating thereto
PL223869B1 (pl) 2013-12-16 2016-11-30 Starogardzkie Zakłady Farm Polpharma Spółka Akcyjna Sposób otrzymywania wardenafilu i jego soli
CN107383020A (zh) * 2017-07-29 2017-11-24 合肥创新医药技术有限公司 一种伐地那非杂质的制备方法
JP2021506986A (ja) 2017-12-20 2021-02-22 クラリア・ファルマ・ホールディング・アクチボラグ バルデナフィルを含むフィルム配合物、その調製法、およびその使用
CN115043757B (zh) * 2022-07-27 2023-08-08 南京桦冠生物技术有限公司 一种连续化制备苄脒盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
EP1049695B1 (de) * 1997-11-12 2002-02-13 Bayer Ag 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
DE10063108A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Herstellung von Sulfonamid-substituierten Imidazotriazinonen
DE10107639A1 (de) * 2001-02-15 2002-08-22 Bayer Ag 2-Alkoxyphenyl-substituierte Imidazotriazinone

Also Published As

Publication number Publication date
ES2266098T3 (es) 2007-03-01
BG66142B1 (bg) 2011-07-29
PE20020590A1 (es) 2002-07-13
KR20030063430A (ko) 2003-07-28
TWI289562B (en) 2007-11-11
WO2002050076A2 (de) 2002-06-27
US6777551B2 (en) 2004-08-17
MA25927A1 (fr) 2003-10-01
DK1345939T3 (da) 2006-09-25
AU2002217089B2 (en) 2006-01-12
GT200100251A (es) 2002-10-01
CZ297005B6 (cs) 2006-08-16
CA2431933A1 (en) 2002-06-27
US20050014756A1 (en) 2005-01-20
BG107892A (bg) 2004-08-31
EP1345939B1 (de) 2006-06-07
HRP20030583A2 (en) 2005-06-30
DE50110080D1 (de) 2006-07-20
HUP0302467A2 (hu) 2003-11-28
PL365310A1 (en) 2004-12-27
SI1345939T1 (sl) 2006-10-31
EP1345939A2 (de) 2003-09-24
CY1105197T1 (el) 2010-03-03
IL156278A (en) 2009-06-15
DOP2001000295A (es) 2002-12-15
MY126689A (en) 2006-10-31
HRP20030583B1 (en) 2011-09-30
PL207294B1 (pl) 2010-11-30
ZA200304705B (en) 2004-08-12
AU1708902A (en) 2002-07-01
UY37172A (es) 2017-06-30
NO20032731D0 (no) 2003-06-16
CU23873B1 (es) 2013-04-19
BR0116227A (pt) 2003-12-30
HK1063799A1 (en) 2005-01-14
NZ526477A (en) 2004-12-24
DE10063108A1 (de) 2002-06-20
UY27070A1 (es) 2002-07-31
HU229296B1 (en) 2013-10-28
SV2003000766A (es) 2003-01-13
WO2002050076A3 (de) 2002-08-29
EE200300294A (et) 2003-10-15
NO20032731L (no) 2003-06-16
KR100787288B1 (ko) 2007-12-20
JP2004517849A (ja) 2004-06-17
RU2299211C2 (ru) 2007-05-20
BR0116227B1 (pt) 2014-08-26
US20020137930A1 (en) 2002-09-26
CN1481386A (zh) 2004-03-10
CU20080213A7 (es) 2012-06-21
HN2001000278A (es) 2002-01-30
NO325398B1 (no) 2008-04-21
MXPA03005429A (es) 2004-05-04
PT1345939E (pt) 2006-08-31
CU23341B7 (es) 2009-02-20
ECSP034657A (es) 2003-07-25
HUP0302467A3 (en) 2004-11-29
ATE328885T1 (de) 2006-06-15
AR032775A1 (es) 2003-11-26
SK286894B6 (sk) 2009-07-06
CN1227253C (zh) 2005-11-16
UA75109C2 (en) 2006-03-15
IL156278A0 (en) 2004-01-04
BRPI0116227B8 (pt) 2021-05-25
SK7502003A3 (en) 2003-10-07
CZ20031692A3 (cs) 2003-10-15
US20050203298A1 (en) 2005-09-15
JP4441175B2 (ja) 2010-03-31
US6998483B2 (en) 2006-02-14
CA2431933C (en) 2009-12-01

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
FI20011621A0 (fi) Menetelmä sitalopraamin valmistamiseksi
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
EE05308B1 (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20042640L (no) Fremgangsmate for fremstilling av ekinocandinderivater
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20026155D0 (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20025465D0 (no) FremgangsmÕte for fremstilling av bifenylforbindelser
NO20024887D0 (no) Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20032297D0 (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20010719L (no) Fremgangsmåte ved fremstilling av n¶rende granuler
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter
ITMI20000334A0 (it) Procedimento di preparazione di miscele cementizie

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner